Browsing Tag
Barclays
15 posts
World’s biggest oil chokepoint closed: What the Iran crisis means for energy prices globally
Iran closes the Strait of Hormuz after US-Israel strikes; Brent crude surges 14% to $83, European gas up 70% as QatarEnergy halts LNG production.
March 3, 2026
Inside Britain’s biggest Gulf trade push: What the £6.4bn deal really means
Find out how the UK secured a £6.4 billion trade and investment deal with Saudi Arabia and what it means for British business and Gulf strategy.
October 30, 2025
TP ICAP acquires Neptune Networks and launches new dealer-to-client credit platform
TP ICAP’s acquisition of Neptune and D2C credit venture with top banks aims to transform bond market liquidity and electronification. Learn how this reshapes fixed income trading.
June 2, 2025
Tesco posts £3.13bn profit and hits decade-high UK share—analysts weigh in on what’s next for investors
Tesco delivered a £3.13bn profit and decade-high UK market share in FY2024/25. Find out what’s driving growth and whether Tesco stock is a buy now.
April 13, 2025
Barclays financial results 2024: Profit before tax soars 24% amid strong capital distributions
Barclays PLC reported a significant improvement in its financial results for 2024, achieving a profit before tax of…
February 15, 2025
SolarWinds to go private after $4.4bn acquisition by Turn/River Capital
In a significant move within the technology sector, SolarWinds Corporation, a leading provider of IT management software, has…
February 10, 2025
Tech turmoil: Cloudflare stock drops on disappointing revenue forecast
Cloudflare’s stock price plunged during premarket trading today, with shares falling sharply as the company’s fourth-quarter and full-year…
November 8, 2024
FEMSA unloads Solistica to Traxion—What does this mean for the future of logistics?
Fomento Económico Mexicano, S.A.B. de C.V. (FEMSA), a major conglomerate in the retail and beverage sectors in Mexico,…
October 10, 2024
Nuvalent’s stock jumps 22% after ESMO 2024 – what’s next for this biotech game-changer?
Nuvalent, Inc., a biopharmaceutical company specialising in targeted cancer therapies, has seen its stock price skyrocket following the…
September 16, 2024
Armada completes merger with Rezolve AI to launch new AI-driven retail platform on Nasdaq
Armada Acquisition Corp. I, a publicly traded special purpose acquisition company, has successfully finalized its business combination with…
August 18, 2024